Compile Data Set for Download or QSAR
maximum 50k data
Found 20 Enz. Inhib. hit(s) with all data for entry = 8177
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235724(US10117875, Example 67 | US9359361, 67)
Affinity DataIC50:  25nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235714(US10117875, Example 54 | US9359361, 54)
Affinity DataIC50:  62nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235721(US10117875, Example 63 | US9359361, 63)
Affinity DataIC50:  112nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235716(US10117875, Example 57 | US9359361, 57)
Affinity DataIC50:  113nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235730(US10117875, Example 73 | US9359361, 73)
Affinity DataIC50:  124nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235727(US10117875, Example 70 | US9359361, 70)
Affinity DataIC50:  137nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235732(US10117875, Example 66 | US9359361, 66)
Affinity DataIC50:  181nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235723(US10117875, Example 65 | US9359361, 65)
Affinity DataIC50:  198nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235725(US10117875, Example 68 | US9359361, 68)
Affinity DataIC50:  273nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235713(US10117875, Example 1 | US9359361, 1)
Affinity DataIC50:  285nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235715(US10117875, Example 56 | US9359361, 56)
Affinity DataIC50:  317nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235729(US10117875, Example 72 | US9359361, 72)
Affinity DataIC50:  487nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235731(US10117875, Example 74 | US9359361, 74)
Affinity DataIC50:  901nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235717(US10117875, Example 59 | US9359361, 59)
Affinity DataIC50:  991nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235718(US10117875, Example 60 | US9359361, 60)
Affinity DataIC50:  2.18E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235726(US10117875, Example 69 | US9359361, 69)
Affinity DataIC50:  2.48E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235720(US10117875, Example 62 | US9359361, 62)
Affinity DataIC50:  2.49E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235722(US10117875, Example 64 | US9359361, 64)
Affinity DataIC50:  2.95E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235728(US10117875, Example 71 | US9359361, 71)
Affinity DataIC50:  3.82E+3nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Janus Biotherapeutics

US Patent
LigandPNGBDBM235719(US10117875, Example 61 | US9359361, 61)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent